Preformulation studies of thymopentin: analytical method development, physicochemical properties, kinetic degradation investigations and formulation perspective

被引:8
|
作者
Liu, Mengyang [1 ]
Svirskis, Darren [1 ]
Proft, Thomas [2 ,3 ]
San Loh, Jacelyn Mei [2 ,3 ]
Wen, Jingyuan [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Sch Pharm, 95 Pk Rd, Auckland, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland, New Zealand
[3] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand
关键词
Thymopentin; preformulation; HPLC; physical and chemical properties; forced degradation kinetics; partition and distribution coefficient; enzymatic degradation kinetics; enzymatic inhibitions; microemulsion; DELIVERY;
D O I
10.1080/03639045.2022.2048666
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thymopentin (TP5) is a synthetic pentapeptide with immunomodulatory properties. Given the previously described poor absorption of TP5, preformulation data is required to support effective formulation development. In this manuscript, an analytical method of TP5 was developed and validated to determine the aqueous solubility, stability, and Log P of TP5. Thermal properties were investigated, and chemical, physical and enzymatic degradation were evaluated. TP5 was informed to load in a microemulsion (ME) system according to the preformulation parameters and characterized for rheological behavior, droplet size, morphology and in vitro drug release. TP5 displayed high aqueous solubility (294.3 mg/mL), low Log P (-4.2) and 2% water content with a melting temperature of 193 degrees C. TP5 degraded rapidly in alkaline conditions, at elevated temperature, in oxidizing agents, and with UV exposure, however TP5 had a longer half-life in acidic conditions. The fastest enzymatic degradation was with Trypsin (half-life 6.3 h) compared with other digestive enzymes. The different degradation pathways followed first-order kinetics, and half-lives were obtained from the kinetic studies. The TP5 loaded ME exhibited a droplet size of 143 +/- 35 nm with a Higuchi-model fitted sustained release profile for 24 h. These data justify and support the design of formulations to stabilize and enhance the absorption of TP5, with a ME formulation demonstrated.
引用
收藏
页码:1680 / 1692
页数:13
相关论文
共 32 条
  • [1] Preformulation studies of l-glutathione: physicochemical properties, degradation kinetics, and in vitro cytotoxicity investigations
    Liu, Mengyang
    Sharma, Manisha
    Lu, Guo-Liang
    Yin, Naibo
    Al Gailani, Murad
    Sreebhavan, Sree
    Wen, Jingyuan
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2020, 46 (05) : 717 - 731
  • [2] Agrochemical forced degradation studies and their role in analytical method and formulation development
    Malkin, Douglas
    Samame, Renzo
    Bishop, Michael
    Knueppel, Daniel
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [3] Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization
    Shete, Harshad
    Patravale, Vandana
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 454 (01) : 573 - 583
  • [4] A preformulation study of marine alkaloid aaptamine: Physicochemical properties investigation and liposomal formulation development toward hepatocellular carcinoma treatment
    Geng, Tianjiao
    Xue, Haitao
    Kong, Can
    He, Luping
    Wang, Shuping
    Ding, Ling
    Zou, Xiaoyan
    Gu, Zhichun
    Liao, Hongze
    Lin, Houwen
    [J]. EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2024,
  • [5] Characterization, thermal stability studies, and analytical method development of Paromomycin for formulation development
    Khan, Wahid
    Kumar, Neeraj
    [J]. DRUG TESTING AND ANALYSIS, 2011, 3 (06) : 363 - 372
  • [6] Analytical method development, validation and studies of degradation behavior of erlotinib hydrochloride in bulk and tablet formulation by thin-layer chromatography
    Hardik L. Varu
    Rajesh A. Jadav
    Atul H. Bapodra
    Mrunal A. Ambasana
    [J]. JPC – Journal of Planar Chromatography – Modern TLC, 2023, 36 (4): : 307 - 313
  • [7] Analytical method development, validation and studies of degradation behavior of erlotinib hydrochloride in bulk and tablet formulation by thin-layer chromatography
    Varu, Hardik L.
    Jadav, Rajesh A.
    Bapodra, Atul H.
    Ambasana, Mrunal A.
    [J]. JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2023, 36 (04) : 307 - 313
  • [8] ANALYTICAL METHOD DEVELOPMENT AND PREFORMULATION STABILITY STUDIES OF L-665,871 (A BETA-AGONIST) IN SWINE FEED
    DEMONTIGNY, P
    DAVE, KJ
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1993, 11 (10) : 947 - 954
  • [9] Studies of the Physicochemical Properties of a New Compound with Kappa-Opioid Agonist Activity, RU 1205, and Development of an Analytical Method
    A. A. Illarionov
    L. N. Grushevskaya
    L. M. Gaevaya
    M. E. Dudenkova
    N. I. Avdyunina
    B. M. Pyatin
    F. S. Baiburtskii
    V. P. Lezina
    [J]. Pharmaceutical Chemistry Journal, 2014, 48 : 350 - 356
  • [10] Studies of the Physicochemical Properties of a New Compound with Kappa-Opioid Agonist Activity, RU 1205, and Development of an Analytical Method
    Illarionov, A. A.
    Grushevskaya, L. N.
    Gaevaya, L. M.
    Dudenkova, M. E.
    Avdyunina, N. I.
    Pyatin, B. M.
    Baiburtskii, F. S.
    Lezina, V. P.
    [J]. PHARMACEUTICAL CHEMISTRY JOURNAL, 2014, 48 (05) : 350 - 356